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Summary
Skin-derived precursors (SKPs) are embryonic neural crest-
or somite-derived multipotent progenitor cells with prop-
erties of dermal stem cells. Although a large number of
studies deal with their differentiation ability and poten-
tial applications in tissue damage repair, only a few stud-
ies have concentrated on the regulation of SKP self-
renewal. Here, we found that after separation from their
physiological microenvironment, human foreskin-derived
SKPs (hSKPs) quickly senesced and lost their self-renewal
ability. We observed a sharp decrease in Akt activity dur-
ing this process, suggesting a possible role of the PI3K-
Akt pathway in hSKP maintenance in vitro. Blocking this
pathway with several inhibitors inhibited hSKP prolifera-
tion and sphere formation and increased hSKP senes-
cence. In contrast, activating this pathway with PDGF-AA
and a PTEN inhibitor, bpV(pic), promoted proliferation,
improved sphere formation, and alleviated senescence of
hSKPs, without altering their differentiation potential.
Data also implied that this effect was associated with
altered actions of FoxO3 and GSK-3b. Our results suggest
an important role of the PI3K-Akt pathway in the senes-
cence and self-renewal of hSKPs. These ﬁndings also pro-
vide a better understanding of the cellular mechanisms
underlying hSKP self-renewal and stem cell senescence to
allow more efﬁcient expansion of hSKPs for regenerative
medical applications.
Key words: skin-derived precursors; PI3K-Akt; self-
renewal; cellular senescence; adult stem cells; PTEN.
Introduction
Among various adult stem cell types within the skin, the newly
identiﬁed skin-derived precursors (SKPs) have been extensively
investigated in recent years because of their multipotent differ-
entiation ability and potential clinical applications. SKPs could
differentiate into neurons, glial cells, adipocytes, muscular cell
types, insulin-producing cells, and so forth (Qiu et al., 2010;
Toma et al., 2001; Guo et al., 2009). Studies also pointed out
that murine facial SKPs originated from embryonic neural crest,
and dorsal trunk SKPs originated from the somites. SKPs persist
into adulthood, with dermal papillae (DP) of hair follicles as one
niche for them (Fernandes et al., 2004; Hunt et al., 2008; Jinno
et al., 2010). It has recently been shown that SKPs exhibit
properties of dermal stem cells that contribute to dermal
maintenance, wound healing, and hair follicle morphogenesis
(Biernaskie et al., 2009). Therefore, SKPs have great potential in
skin and hair follicle reconstitution, and as a donor cell type for
the repair of many other tissues. Realizing the therapeutic
potential of SKPs in human requires strategies to generate not
only a particular functional cell type, but also a considerable cell
quantity for transplantation. However, although SKPs have been
successfully isolated from human skin (Toma et al., 2005), some
fundamental questions remain intangible, especially those con-
cerning their self-renewal regulation. Previously, we found that
human foreskin-derived SKPs (hSKPs for short in this article)
could not maintain long-term self-renewal in the commonly
used suspension culture system, consistent with the report by
Gago et al. (2009).
In the present study, we explored the regulation of hSKP self-
renewal and its underlying mechanisms. We found that hSKPs
quickly became senescent under current culture condition,
which was at least partially responsible for their loss of self-
renewal ability. Senescence and aging of stem cells have been
studied, but their regulation remains largely uninvestigated. We
focused on phosphatidylinositol 3-kinase (PI3K)-Akt (PI3K-Akt)
pathway because of its well-established role in controlling cell
proliferation, survival, as well as senescence. For the whole
organism, this pathway is strongly linked to aging and lifespan
regulation because it can profoundly change the numbers and
activity of different types of stem cells (Sahin & DePinho, 2010).
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lIn mouse and primate embryonic stem cells (ESCs), activation of
Akt signaling is sufﬁcient to maintain their pluripotency
(Watanabe et al., 2006). In-vivo and in-vitro studies revealed a
crucial role of the PI3K-Akt pathway in self-renewal and
differentiation of neural stem⁄progenitor cells (Groszer et al.,
2001, 2006; Sinor & Lillien, 2004; Gregorian et al., 2009).
Because SKPs were ﬁrst isolated using culture condition for
neural stem⁄progenitor cells and these two stem⁄progenitor cell
types exhibit similar properties, the PI3K-Akt pathway is a good
candidate for the regulation of hSKP self-renewal and cellular
senescence.
In this study, hSKP senescence in vitro was investigated, with
a focus on the role of the PI3K-Akt pathway. Our study eluci-
dated the basis for the lack of in-vitro expansion of adult hSKPs
that were observed by several groups (Joannides et al., 2004;
Gago et al., 2009). We also suggested that the PI3K-Akt path-
way played a role in the maintaining hSKPs in vitro and stimula-
tion of this pathway by PDGF-AA and bpV(pic) provided an
improved in-vitro expanding condition for hSKPs.
Results
Isolation and characterization of hSKPs
The hSKPs can be routinely isolated and cultured from human
foreskin. During primary culture, most of dermal cells adhered
to culture dishes or died while a portion of cells aggregated to
form spheres, which could be passaged by trypsinization and
pipetting as shown in Fig. S1A (Supporting information). As
reported before, these hSKPs expressed nestin, ﬁbronectin, and
vimentin (Fig. S1B). Using reverse transcription–polymerase
chain reaction (RT–PCR), we also detected several embryonic
neural crest stem cell markers, p75 neurotrophin receptor
(p75NTR), Pax3, Slug, and Snail in hSKPs (Fig. S1C), which were
also reported to be expressed by hSKPs (Toma et al., 2005).
Totestthedifferentiationpotentialofthesecells,Day12hSKPs
were differentiated under different conditions for 2–4 weeks. At
the end of the assay, cells positive for smooth muscle alpha actin
(a-SMA), Oil-Red O, b-III-tubulin, major microtubule-associated
protein2(MAP2),andS100protein wereobserved(Fig. S1D–G),
suggesting the differentiation into smooth muscle cells, adipo-
cytes, neurons, and glial cells. The results showed that these
hSKPshadmultipledifferentiationpotentials.
hSKPs quickly became senescent in culture and could
not maintain their self-renewal ability
Unlike newborn murine SKPs reported by Toma et al. (2001),
our adult foreskin-derived SKPs could not sustain long-term self-
renewal in vitro in suspension. Figure 1A showed the sphere-
forming ability of hSKPs from three independent donors, which
were 23, 30, and 9 years old at different passages. Sphere-form-
ing efﬁciency was relatively low at Passage 0 (P0) as a result of
cellular heterogeneity in culture and peaked at Passage 1–3,
with differences between individual donors. However, sphere-
forming rate sharply dropped after P3 or P4 (Fig. 1A). As a
result, cell expansion after P4 was extremely poor. Table S1
(Supporting information) shows the detailed information of
these three independent cultures. Thus, we carried out a series
of assays to elucidate the underlying mechanisms.
Firstly, we checked cell apoptosis. We detected apoptotic
hSKPs using TUNEL assay (terminal deoxynucleotidyl transferase
dUTP nick end labeling) (Fig. 1B). We found that TUNEL-positive
hSKPs only accounted for < 15% of all hSKPs within a sphere.
We compared the percentage of apoptotic hSKPs in spheres on
Day 12 (P1) and Day 24 (P3). Changes in the apoptotic hSKP
ratio were more likely due to variations in different donors rather
than culture time or passage. To conﬁrm this, we examined
cleaved caspase-3, the active form of caspase-3 as another
apoptotic indicator. Western blot results from three samples
showed that the level of cleaved caspase-3 did not change dur-
ing culture, indicating no increase in hSKP apoptosis (Fig. 1C),
consistent with TUNEL analysis (Fig. 1B). These data showed
that apoptosis did not contribute to the loss of hSKP self-
renewal in vitro.
Next, we examined cell proliferation of hSKPs using ki67 stain-
ing. We observed a general decline in ki67-positive cell ratios
over time (Fig. 1D,E), indicating an overall decrease in hSKP pro-
liferation. We examined the expression of a G1 phase cyclin,
cyclin D1, usingquantitative real-timePCR andWesternblot.Cy-
clin D1 expression was elevated during culture (Fig. 1F), which
together with decreased proliferation suggested G1 phase cell
cycle arrest. This implied the phenomenon of cellular senes-
cence, which is characterized by G1 phase arrest (Garkavtsev
et al., 1998) andcyclin D1 up-regulation (Hanet al.,1999).
Therefore, we investigated cellular senescence of cultured
hSKPs. Senescence-associated beta gal (SA-b-gal) expression
was evident in cultured hSKPs, indicating hSKPs were undergo-
ing senescence. To study the time-dependent senescence in
hSKPs, we compared SA-b-gal staining in freshly isolated dermal
cells containing putative hSKPs (Day 0), Day 6 hSKPs, Day 12
hSKPs, and Day 24 hSKPs. We observed that although a minority
of Day 0 cells showed weak staining (indicated by arrow heads,
upper panel, Fig. 1G), most of the cells were unstained. Day 6
spheres showed evident staining and staining became stronger
later on (upper panels, Fig. 1G). To quantitate this change, we
categorized hSKP spheres into three types according to the
extent of SA-b-gal staining. Type A were spheres with nearly no
staining; Type B were spheres with moderate staining (< 50%
cells showed staining within a sphere); Type C were spheres with
intense staining (‡ 50% cells showed staining within a sphere)
(right panels, Fig. 1G). We compared portions of each type of
sphere at different time points and made a time-dependent
curve. As shown in the lower panels, Fig. 1G, in hSKPs derived
from three independent donors, Type A and Type B spheres
decreased over time (green and yellow lines) while Type C
spheres increased sharply (red lines). For hSKPs from the older
donor(38 yearsold),thechangeduring ﬁrst12 dayswasgreater
than those from the other two donors (both 23 years old), as
indicated bymuch smallerTypeAportion andbigger TypeCpor-
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Fig. 1 Human foreskin-derived skin-derived precursors (hSKPs) quickly senesced in culture and lost their self-renewal ability. (A) Sphere-forming efﬁciency of
hSKPs from three independent donors (23, 30, and 9 years old) at different passages. (B) TUNEL assay of hSKPs on Day 12 and Day 24 of culture. On the left shows
representative staining of hSKPs incubated without Enzyme Solution as a negative control (the upper panel), DNase-treated hSKPs as a positive control (the middle
panel), and normal hSKPs with apoptotic cells labeled green (the lower panel). PI was used for counterstaining. The histogram on the right shows TUNEL-positive
hSKP percentages of two independent donors (21 and 22 years old) on Day 12 and Day 24. Scar bar = 20 lm. (C) Western blot assay of cleaved caspase-3 levels in
hSKPs on Day 6, Day 12, and Day 18, which showed no statistically signiﬁcant difference. The upper panel shows the statistical results of gray-scale analysis of
three independent experiments, and lower panels show a representative Western blot result. (D) Immunostaining of Ki67 of hSKPs on Day 6, Day 12, Day 18, and
Day 24 from a representative culture (donor age = 33). PI was used for counterstaining. (E) Statistical results of Ki67-positive hSKP percentages on Day 6, Day 12,
Day 18, and Day 24 of cultures from two donors (33 and 9 years old). (F) Expression of cyclin D1 in hSKPs at different culture time. The left panel shows the relative
expression of cyclin D1 mRNAs on Day 12 and Day 24 in hSKPs from a 22-year-old donor (by quantitative real-time PCR assay). Double asterisks mean P < 0.01
when Day 24 was compared with Day 12. The histogram on the right shows the statistical results of relative expression of cyclin D1 protein on Day 6, Day 12, and
Day 18 in hSKPs from three independent cultures by Western blot, with the result from a representative culture attached below. (G) SA-b-Gal staining of hSKPs at
different culture time. Upper panels show the representative staining of hSKPs from a 23-year-old donor on Day 0, Day 6, Day 12, and Day 24. Right panels show
typical staining patterns of Type A, Type B, and Type C spheres. The three line charts at the bottom show the percentages of each type of sphere on Day 6, Day 12,
and Day 24 from three independent donors. Two donors were young adults (both 23 years old) and the other was older (38 years old). Green lines stand for Type
A spheres. Yellow lines stand for Type B spheres, and red lines stand for Type C spheres. (H) SA-b-Gal staining of hSKPs from a 23-year-old donor cultured in
methylcellulose-containing semisolid media on Day 0, Day 6, Day 12, and Day 24. SA-b-gal: senescence-associated beta gal. TUNEL, terminal deoxynucleotidyl
transferase dUTP nick end labeling; PI, propidium iodide.
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663tion on Day 12. These results raised the possibility that hSKPs
from older donors might have a more rapid senescence process
invitro.
It was reported that methylcellulose-containing semisolid
media could promote cellular expansion and provided a better
culture system for hSKPs (Gago et al., 2009). We also assessed
cellular senescence in semisolid system. As shown in Fig. 1H,
hSKPs still senesced in the semisolid system, indicated by
increasing SA-b-gal staining over time. We compared SA-b-gal
staining of hSKPs in liquid culture and semisolid culture. Human
foreskin-derived SKPs from two out of three donors that we
studied showed reduced senescence (bigger Type A portion and
smaller Type C portion) in the ﬁrst 12 days, but Type C spheres
became predominant on Day 24 in hSKPs from all the three
donors, in both liquid and semisolid cultures (Fig. S2). This result
indicated that methylcellulose culture could not prevent hSKP
senescence. We also assessed cellular senescence when hSKPs
were cultured at relatively low densities. As shown in Fig. S3,
hSKPs passaged at 10
4 cells cm
)2 also showed considerable
SA-b-gal staining at Day 12, indicating that lower densities could
not prevent hSKP senescence, either. These data suggested that
hSKP senescence in vitro could not be prevented simply by the
change of culture method. However, SKPs derived from neona-
tal murine skin showed much weaker SA-b-gal staining at Day
12 of culture (Fig. S4), indicating they were more resistant to
in-vitro senescence compared with adult human SKPs.
We further looked into the molecular events underlying hSKP
senescence process. P53 and p16 are key regulators of cell cycle
and cellular senescence (Beausejour et al., 2003). Western blot
results showed that expression of both proteins were up-regu-
lated during culture, supporting the increased senescence of
hSKPs (Fig. 2A). Besides, we investigated their time-dependent
expression together with the proliferation marker, ki67, at the
cellular level to explore their roles in hSKP senescence. Upon iso-
lation, dermal cells containing the putative hSKPs were all nega-
tive for Ki67 (green), indicating they were quiescent in vivo (Day
0, Fig. 2B,C). A small portion (from none to < 5%, varied
among donors) of Day 0 cells showed weak p53 staining (Day 0,
Fig. 2B, red), while a bigger portion of cells (from 10% to 30%,
varied among donors) were positive for p16 (Day 0, Fig. 2C,
red), suggesting that these cells might be undergoing senes-
cence in vivo. Both p53- and p16-positive cell portions seemed
to increase in hSKP spheres over time (Day 6 to Day 24,
Fig. 2B,C), consistent with Western blot results and previously
observed increasing senescence shown in Fig. 1G. While p53
was only expressed in a small portion of hSKPs (< 20%), even
on Day 24, p16 expression increased sharply over time and
extended to most of the cells on Day 24. Moreover, most of
Ki67-positive cells were p53 negative, while a subset of them
were p16 positive (indicated by co-staining of Ki67 and p16,
arrow heads, Fig. 2B,C), indicating that these cycling cells were
accumulating p16. We also assessed p21 expression in hSKPs by
immunoﬂuorescence, which was also observed in only a small
portion of cells (data not shown). These data suggested that
hSKP senescence was mainly mediated by intracellular accumu-
lation of p16.
Because of the crucial role of the PI3K-Akt pathway in cell pro-
liferation, survival and senescence, and its regulation on nega-
tive regulators of cell cycle, such as p53, p21, and p16, we
examined the change of this pathway at different time points.
Western blot results showed that Akt phosphorylation
decreased sharply on Day 12 and remained low afterward
(Fig. 2D), indicating quickly weakened Akt activity in culture in
concomitant with the rapid senescent process.
Blockage of the PI3K-Akt pathway increased hSKP
senescence and suppressed hSKP self-renewal
Concomitant senescence of hSKPs and decrease in Akt phos-
phorylation suggested a possible role of the PI3K-Akt pathway
in the maintenance of hSKPs in vitro. Therefore, we tried to
block this pathway using a PI3K inhibitor LY294002. However,
at the end of the 12 days of culture, we did not detect the inhi-
bition of Akt phosphorylation in hSKPs cultured with 10 lM
LY294002 (the left panel, Fig. 3A). We assumed that it was pos-
sibly because the basal level of Akt phosphorylation on Day 12
was already very low, rendering the down-regulation difﬁcult to
detect. LY294002 could in fact inhibit the growth factor-
induced Akt phosphorylation in hSKPs (Fig. S5). Also, we used
an inhibitor of Akt1⁄2, ‘Akt inhibitor VIII’ to conﬁrm the speciﬁc-
ity of the Akt pathway. As shown in the right panel, Fig. 3A, a
considerable inhibitory effect of Akt inhibitor VIII (5 lM) on Akt
activity in hSKPs after 12 days was detected.
After a series of assays, which will be discussed in detail
below, we found that both inhibitors substantially impaired
hSKP self-renewal even though LY294002 might not show a vis-
ible inhibition in Akt activity in long-term culture. First of all,
MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazolium) assay was used to study hSKP
growth as it is a commonly used homogeneous, colorimetric
method for determining the viability of cells and often used as a
cell proliferation surrogate. MTS assay showed signiﬁcant
decrease in hSKP growth after LY294002 and Akt inhibitor VIII
treatment for 48 h (Fig. 3B). Ki67 staining further conﬁrmed
that cell proliferation was suppressed by the two inhibitors after
the 48-h treatment (Fig. 3C).
Next, to answer whether blocking the PI3K-Akt pathway
would aggravate cellular senescence of hSKPs, we performed
SA-b-Gal staining on hSKPs cultured with or without LY294002
and Akt inhibitor VIII for 12 days. LY294002 (10 lM) and Akt
inhibitor VIII (5 lM) decreased the portions of spheres with no
staining and moderate staining (Type A and B) while increasing
the portion of spheres with intense staining (Type C) (Fig. 3D),
which suggested they could accelerate hSKP senescence. Also,
we checked the expression of senescence-related markers p53
and p16 by Western blot assay. P53 expression (the left panel,
Fig. 3E) was up-regulated after inhibitor treatment while p16
expression (the right panel, Fig. 3E) was not obviously altered,
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inhibitor treatment.
In routine massive culture, we observed obvious decrease in
sphere diameter of hSKPs cultured with LY294002 or Akt inhibi-
tor VIII compared with control (90.0 and 75.9 vs. 111.5 lm)
(Fig. 3F), suggesting impaired sphere formation. Thus, we per-
formed sphere-forming assays to conﬁrm that. However, in
liquid culture system, the decrease in sphere-forming efﬁciency
in LY294002 and Akt inhibitor VIII groups was not signiﬁcant
compared with the control group (Fig. 3G). Considering that cell
aggregation might confuse true sphere formation in liquid cul-
ture, we further assessed sphere formation in methylcellulose-
containing semisolid culture to rule out this confusion. Spheres
formed 6 days after plating were much smaller than those in
(A) (D)
(B)
(C)
Fig. 2 Molecular events in human foreskin-derived SKP (hSKP) senescence. (A) Western blot assay showing relative expression of p53 (left) and p16 (right) in
hSKPs on Day 6, Day 12, and Day 18. Histograms show statistical results of gray-scale analysis of three independent cultures, and representative immunoblots are
attached below. Asterisk means P < 0.05 when compared with Day 6. (B) Dermal cells on Day 0 and hSKP spheres on Day 6, Day 12, and Day 24 immunostained
for Ki67 (green) and p53 (red) and counterstained with Hoechst (blue). Upper panels only show channels for Ki67 and p53. Lower panels show channels for Ki67,
p53 and Hoechst labeled nuclei. (C) Dermal cells on Day 0 and hSKP spheres on Day 6, Day 12, and Day 24 immunostained for Ki67 (green) and p16 (red) and
counterstained with Hoechst (blue). Upper panels only show channels for Ki67 and p16. Lower panels show channels for Ki67, p16, and Hoechst labeled nuclei.
White arrowheads indicates cells positive for both Ki67 and p16. (D) Western blot results showing Akt phosphorylation in hSKPs on Day 6, Day 12, and Day 18. The
histogram shows the statistical results of gray-scale analysis of three independent cultures and representative immunoblots are attached below. Asterisk means
P < 0.05 when compared with Day 6.
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(E)
Fig. 3 Effects of PI3K and Akt inhibitors on human foreskin-derived skin-derived precursors (hSKPs). (A) Western blot results showing Akt phosphorylationi n
hSKPs cultured with 0.1% DMSO as a control and 10 lM LY294002 (the left panel) or 5 lM Akt inhibitor VIII (the right panel). Histograms show statistical results of
gray-scale analysis of three independent cultures and representative immunoblots are attached below. Asterisk means P < 0.05 when compared with control.
(B) MTS assays of hSKPs treated with DMSO (as a control), LY294002 or Akt inhibitor VIII for 48 h. The statistical results were derived from three independent
experiments. Asterisk means P < 0.05 when compared with control. (C) Proliferation of hSKPs after treatment with DMSO (as a control), LY294002 or Akt
inhibitor VIII for 48 h shown by Ki67 staining. Left panels show representative hSKP sphere staining and the histogram on the right shows the statistical results
from three independent cultures. Asterisk means P < 0.05 when compared with control. (D) SA-b-Gal staining of hSKPs cultured with DMSO (as a control),
LY294002 or Akt inhibitor VIII for 12 days. Upper panels show representative staining in different groups and lower histograms show the percentages of three
types of spheres described previously. (E) Western blot assay showing relative expression of p53 (the left panel) and p16 (the right panel) in hSKPs cultured with
DMSO (as a control), LY294002, or Akt inhibitor VIII for 12 days. Histograms show the results of gray-scale analysis and representative immunoblots are attached
below. (F) Morphology of hSKP spheres formed in conditions with DMSO (as a control), LY294002 or Akt inhibitor VIII in a typical culture. Group names are labeled
on the top and mean diameters of spheres are given at the bottom. (G) Sphere-forming efﬁciency of hSKPs cultured with DMSO (as a control), LY294002 or Akt
inhibitor VIII in liquid culture system. The efﬁciency was presented as number of spheres formed form 10
4 cells. (H) Sphere-forming assay of hSKPs treated with
inhibitors of the PI3K-Akt pathway in semisolid media containing methylcellulose. (a) Number of spheres with diameters from 30 to 50 lm formed from 10
4 hSKPs
in the presence of 0.1% DMSO (control), 10 lM LY294002 or 5 lM Akt inhibitor VIII. (b) Number of spheres with diameters > 50 lm formed from 10
4 hSKPs in the
presence of 0.1% DMSO (control), 10 lM LY294002, or 5 lM Akt inhibitor VIII. (c) Number of spheres with diameters > 30 lm formed from 10
4 hSKPs in the
presence of 0.1% DMSO (control), 10 lM LY294002 or 5 lM Akt inhibitor VIII. Sphere number of each treatment in c equals the combination of those in a and b.
Data show the results derived from a 25-year-old donor (blue columns) and a 31-year-old donor (yellow columns). Each treatment had triplicates, and results were
statistically analyzed. Asterisk means P < 0.05 when compared with control. MTS, (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-
2H-tetrazolium).
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666liquid culture system. Only spheres with diameters longer than
30 lm were counted. As shown in Fig. 3H, PI3K and Akt inhibi-
tors reduced the total number of spheres formed from 10
4 cells
(Fig. 3H-c), and spheres with diameters longer than 50 lm were
nearly abolished under such conditions (Fig. 3H-b). Thus,
LY294002 and Akt inhibitor VIII could bona ﬁde inhibit hSKP
sphere formation at the used doses. Taken together, these
results showed that block of the PI3K-Akt pathway suppressed
hSKP proliferation and sphere formation while increasing hSKP
senescence in vitro, which reﬂected a potential crucial role of
this pathway in the maintenance of hSKP self-renewal.
Treatment with PDGF-AA and bpV(pic) improved
self-renewal of hSKPs and alleviated their
senescence in vitro
Further, we investigated whether enhancing the PI3K-Akt path-
way would improve the growth of hSKPs in vitro. We tested sev-
eral growth factors, chemical compounds, and peptides.
According to their receptor expression and effects, we chose
PDGF-AA whose receptors were expressed in hSKPs (Fig. S6)
and a PTEN inhibitor, bpV(pic). MTS assay of hSKPs cultured with
bpV(pic) at different doses for 48 h indicated that 5 and 10 lM
bpV(pic) could improve hSKP growth while 30 lM showed cellu-
lar toxicity and harmed cell growth (Fig. S7A). Thus, we chose
5 lM as the proper dose. Next, we checked the dose range of
PDGF-AA and the combination of PDGF-AA and bpV(pic). As
shown in Fig. S7B, higher dose of PDGF-AA (50 ng mL
)1) had
no signiﬁcant effect compared with 10ng mL
)1 after 48 h treat-
ment. However, the combination of PDGF-AA and bpV(pic)
showed a better mitogenic effect than their separate effects
(Fig. 4A). The effects of PDGF-AA and bpV(pic), alone or in com-
bination, were all blocked by 10 lM LY294002 (Fig. 4A), indicat-
ing the mediation by PI3K-Akt. As shown in Fig. 4B, during a
6-day culture, growth of hSKPs treated with combination of
PDGF-AA and bpV(pic) was improved in comparison with the
control. Although the cell number still decreased in both groups
on Day 6, this might be caused by absence of medium change
during the entire 6-day assay.
Next, cell proliferation was assessed by Ki67 staining. As one
can see from Fig. 4C, almost as shown in the MTS assay,
bpV(pic) alone had a substantial mitogenic effect while the
effect of PDGF-AA alone was not signiﬁcant as the percentage
of Ki67-positive hSKPs was not increased after PDGF-AA treat-
ment. However, PDGF-AA could somehow help improve the
effect of bpV(pic), resulting in a better increase in Ki67-positive
cell portion in PDGF-AA and bpV(pic) combination group com-
pared with bpV(pic) group. Also, the increase in Ki67-positive
hSKP portion by PDGF-AA and bpV(pic) could be counteracted
by Akt inhibitor VIII, further conﬁrming the mediation by the
PI3K-Akt pathway.
Moreover, we checked the cellular senescence using SA-b-gal
staining. hSKP spheres were also divided into three types. As
shown in Fig. 4D, bpV(pic) most efﬁciently increased Type A
sphere portion and decreased Type C sphere portion. Besides,
theintensityofstainingintrypsinizedsinglehSKPswasweakened
in bpV(pic) containing groups (Fig. 4E). In contrast, the effect of
PDGF-AA alone was not signiﬁcant, which was in line with other
ﬁndings above. The SA-b-gal staining results in Figs 1G, 3D and
4DwerecombinedinFig. S8forbettercomparison.
In routine culture, PDGF-AA and bpV(pic) could increase hSKP
sphere size (Fig. 4F). Sphere-forming assay in liquid culture
showed that both PDGF-AA and bpV(pic) could promote
sphere-forming efﬁciency of hSKPs, and their combined effect
was the best (Fig. 4G). Also, sphere formation in semisolid cul-
ture indicated that both PDGF-AA and bpV(pic) could increase
total sphere number formed from 10
4 cells (Fig. 4H-c), and
bpV(pic), alone or with PDGF-AA, can largely increase the num-
ber of spheres with diameters longer than 50 lm (Fig. 4H-b).
To test whether hSKPs remained multipotent after treatment,
we differentiated hSKPs cultured for 12 days with or without
PDGF-AA and bpV(pic). We employed three differentiation con-
ditions and used a-SMA, b-III-Tubulin, S100 and Oil-Red O to
detect smooth muscular, neuronal, glial, and adipocytic cell lin-
eages. After 21-day differentiation, both treated and control
hSKPs generated cells positive for these markers (Fig. 4I). Quan-
titation of marker expression in each condition was shown in
Table 1. No statistically signiﬁcant difference was observed in
the derivation of each type of cell from hSKPs precultured with
or without PDGF-AA and bpV(pic), implying that treatment of
PDGF-AA and bpV(pic) did not change the differentiation poten-
tial of hSKPs.
PDGF-AA and bpV(pic) inhibited key activators of
cellular senescence and down-regulated the
activity of FoxO3 and GSK-3b
As downstream signal components of Akt such as FoxOs and
GSK-3b were reported to be involved in cellular senescence, we
investigated changes of these proteins in treated hSKPs. After
12 days of culture, Akt activity was slightly stronger in PDGF-AA
and bpV(pic) treated hSKPs than the control group, and the
combination of PDGF-AA and bpV(pic) resulted in increased Akt
phosphorylation (Fig. 5A). We next analyzed the inhibition of
FoxO3 levels, and we found that all treated groups showed low-
ered FoxO3 phosphorylation indicating reduced activity
(Fig. 5B). Likewise, GSK-3b was also inhibited in treated groups,
implied by its increased phosphorylation (Fig. 5C). Therefore,
both FoxO3 and GSK-3b pathways could be regulated during
PDGF-AA- and bpV(pic)-induced hSKP senescence alleviation.
Furthermore, we studied the changes in the expression of sev-
eral key senescence regulators (Fig. 5D–F). P53, p21, and p16
protein levels were all down-regulated in treated groups. The
effect of PDGF-AA alone was not so signiﬁcant, which was in
line with the fact that it only slightly alleviated hSKP senescence.
However, it seemed to augment the effect of bpV(pic) as the
combination group showed stronger inhibition of these three
proteins than bpV(pic) alone.
Given the fact that PDGF-AA could also activate the MAPK
pathway, we checked the activity of p38 MAPK, p44⁄42
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(a) (b) (c)
(a) (b) (c)
Fig. 4 Effects of PDGF-AA and bpV(pic) on human foreskin-derived skin-derived precursors (hSKPs). (A) MTS assay of hSKPs treated for 48 h with PDGF-AA,
bpV(pic) or LY294002, in different combinations. Buffer-treated group was used as control. Asterisk means P < 0.05 when two labeled groups were compared.
(B) MTS growth curves of hSKPs treated with or without the combination of PDGF-AA and bpV(pic) for 6 days. The red line stands for PDGF-AA + bpV(pic) group,
and the blue line stands for the buffer-treated control group. (C) Ki67-positive cell percentages in hSKPs treated for 48 h with PDGF-AA, bpV(pic) and Akt inhibitor
VIII, in different combinations. Asterisk means P < 0.05 when two labeled groups were compared. (D) SA-b-Gal staining of hSKP spheres treated for 12 days
without (control) or with PDGF-AA, bpV(pic) and their combination. Upper panels show representative staining in different groups and lower histograms show the
percentages of three types of spheres described previously. (E) Representative SA-b-Gal staining of trypsinized hSKPs treated 12 days without (control) or PDGF-
AA, bpV(pic) and their combination. Intensity of staining is noteworthy. (F) Morphology of hSKP spheres (from a 30-year-old donor) formed in conditions without
(control) or with PDGF-AA, bpV(pic) and their combination. Group names are labeled on the top and mean diameters of spheres are given at the bottom. (G)
Sphere-forming assay of hSKPs treated without (control) or with PDGF-AA, bpV(pic) and their combination in liquid culture system. Asterisk means P < 0.05 when
compared with control. (H) Sphere-forming assay of hSKPs treated with PDGF-AA and bpV(pic) in semisolid media containing methylcellulose. (a) Number of
spheres with diameters from 30 to 50 lm formed from 10
4 hSKPs in the presence of 10 ng mL
)1 PDGF-AA, 5 lM bpV(pic) or their combination. Buffer-treated
group was used as control. (b) Number of spheres with diameters > 50 lm formed from 10
4 hSKPs in the presence of 10 ng mL
)1 PDGF-AA, 5 lM bpV(pic) or
their combination. Buffer-treated group was used as control. c. Number of spheres with diameters > 30 lm formed from 10
4 hSKPs in the presence of
10 ng mL
)1 PDGF-AA, 5 lM bpV(pic) or their combination. Buffer-treated group was used as control. Sphere number of each treatment in c equals the
combination of those in a and b. Data show the results derived from a 25-year-old donor (blue columns) and a 31-year-old donor (yellow columns). Each treatment
had triplicates, and results were statistically analyzed. Asterisk means P < 0.05 when compared with control. (I) Staining of differentiation markers, a-SMA (green),
b-III-tubulin (green), S100 protein (green) and Oil-Red O (red), in hSKPs precultured without (control, left panels) or with the combination of PDGF-AA and bpV(pic)
(right panels) after a 21-day differentiation. PI or hematoxylin was used for counterstaining. a-SMA, smooth muscle alpha actin; PI, propidium iodide. MTS, (3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium).
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668Table 1 Quantitation of the percentage of differentiated progeny derived from human foreskin-derived skin-derived precursors cultured in the presence or
absence of the combination of PDGF-AA and bpV(pic)
Percentage of differentiated cells positive for a certain marker [control vs. PDGF-AA + bpV(pic)] (Mean ± SEM)
Differentiation conditions Condition A Condition B Condition C
Marker
b-III-tubulin 2.9 ± 0.9 vs. 1.8 ± 0.3 7.4 ± 1.3 vs. 12.3 ± 2.4 N ⁄A
a-SMA 12.9 ± 2.8 vs. 18.4 ± 6.7 7.9 ± 1.6 vs. 7.9 ± 1.8 N ⁄A
S100 Rare 13.2 ± 0.4 vs. 14.9 ± 2.7 N ⁄A
Oil-red O Rare N ⁄ A 35.7 ± 3.8 vs. 35.6 ± 2.1
None of the pairs of data showed statistically signiﬁcant difference (i.e. P > 0.05 in t-test).
Condition A: DMEM ⁄F12 with 1% fetal bovine serum (FBS).
Condition B: Neurobasal medium with 1% N2 supplement, 4 lM forskolin, 10 ng mL
)1 heregulin and 1% FBS.
Condition C: DMEM ⁄F12 with 1 mM dexamethasone, 1 mM isobutylmethylxanthine, 20 lgm L
)1 insulin and 10% FBS.
N ⁄ A, not applicable; a-SMA, smooth muscle alpha actin.
(A) (B) (C)
(E)
(H) (I) (G)
(F) (D)
Fig. 5 Western blot assay of relevant signal molecules in human foreskin-derived skin-derived precursors (hSKPs) cultured for 12 days in different conditions.
(A–C) Phosphorylation of Akt, FoxO3, and GSK-3b in hSKPs cultured without (control) or with PDGF-AA, bpV(pic), and their combination. (D–F) Relative expression
of p53, p21, and p16 in hSKPs cultured without (control) or with PDGF-AA, bpV(pic), and their combination. (G–I) Phosphorylation of p38 MAPK, p44 ⁄42 MAPK,
and SAPK ⁄JNK in hSKPs cultured without (control) or with PDGF-AA, bpV(pic), and their combination. Histograms show statistical results of gray-scale analysis of
three independent cultures and representative immunoblots are attached below. Asterisk means P < 0.05 when compared with control.
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I, the activity of these MAPKs was not up-regulated in PDGF-
AA-treated hSKPs. bpV(pic) treatments seemed to down-regu-
late p38 MAPK. Based on these results, we propose that the
alleviated senescence and promoted self-renewal of hSKP by
PDGF-AA and bpV(pic) were not mainly mediated by MAPK
pathways.
Discussion
Although SKPs have received intensive attention from research-
ers in recent years, only a few studies focused on human SKP
regulation and in-vitro culture even though some groups did
notice that the widely used culture condition could not support
a long time expansion of human SKPs (Joannides et al., 2004;
Gago et al., 2009). Considering the potential use of hSKPs, a
potential dermal stem cell type which could easily be derived
from foreskins and other skin biopsies, insights into self-renewal
control of human SKPs is important. In this study, we addressed
several basic questions.
First, we found that cellular senescence was an important rea-
son for the failure of hSKP expansion in vitro. Cellular senes-
cence is a state of growth arrest (Campisi & d’Adda di Fagagna,
2007). Although cellular senescence has been studied inten-
sively, there is a relative lack in the study about stem cell senes-
cence, which is yet important because stem cells maintain many
tissues throughout life. Cellular senescence can be triggered by
telomere shortening, known as replicative senescence, which
happens gradually after many cell divisions (Herbig et al., 2004).
In our system, accelerated senescence of hSKPs in culture was
not likely induced by cell doubling and telomere shortening.
Indeed, cellular senescence can also be triggered by other stim-
uli, such as DNA damage, oncogene activation, oxidative stress,
lack of nutrients or growth factors, and improper cell contacts
(Ben-Porath & Weinberg, 2005). It is possible that hSKP senes-
cence might be a physiologically associated phenomenon which
is aggravated in vitro. Dermal cells already express senescence
activating signals (mainly p16) to certain levels in vivo, which
was in line with the observation by Ressler et al. (2006). Aug-
ment and accumulation of these signals in hSKPs after separated
from their niche might inhibit their mitogenic response to
growth factors, and in turn the lead to their senescent pheno-
type. Our preliminary data also suggested that the in-vitro senes-
cence might be related to donor age, but more samples will be
required to systematically study this relationship in the future.
Second, we uncovered a role of the PI3K-Akt pathway in
hSKPs. As one of the most important signal pathways, the PI3K-
Akt pathway has been reported to function in a variety of stem
cell types. It was demonstrated that the PI3K-Akt pathway is cru-
cial for the self-renewal of ESCs (Paling et al., 2004), and activa-
tion of Akt signaling was sufﬁcient to maintain pluripotency in
mouse and primate ESCs (Watanabe et al., 2006). Components
of PI3K pathway were also reported to be involved in the self-
renewal of neural stem⁄progenitor cells, with a key role of PTEN
as a negative regulator (Groszer et al., 2001, 2006; Gregorian
et al., 2009). In the skin, the well-documented role of PI3K-Akt
pathway in several types of tumors is thought to be related to
stem cells resident in the skin, including epidermal stem cells
(Murayama et al., 2007) and skin melanocyte stem cells (Inoue-
Narita et al., 2008). Interestingly, SKPs or their derivatives were
recently proposed to be the cell origin of dermal neuroﬁbroma
(Le et al., 2009). The role of PI3K signaling in neuroﬁbromas
(Zhu & Parada, 2002) suggested its potential role in SKP self-
renewal. With regard to cellular senescence, different studies
revealed different yet important roles of PI3K-Akt signaling as
an inhibitor or an activator (Collado et al., 2000; Nogueira et al.,
2008). Akt, as a multifunctional signal molecule that governs cell
survival, senescence, metabolism, and so forth, could induce dif-
ferent effects in different contexts and eventually act for or
against senescence. Here, senescence and loss of self-renewal
of hSKPs were accompanied by decreased Akt activity. Further
inhibition of Akt phosphorylation aggravated the situation. In
contrast, enhanced Akt activation by PDGF-AA and bpV(pic) did
reduce hSKP senescence and promoted self-renewal. Future
work is needed to elucidate detailed role of the PI3K-Akt path-
way in SKP behavior in vitro and in vivo.
Further, we ameliorated hSKP senescence and improved their
self-renewal in vitro using a growth factor and a chemical com-
pound, which enhanced the activity of the PI3K-Akt pathway.
Although cellular senescence normally acts as tumor-suppress-
ing mechanism in the case of DNA damage and oncogene acti-
vation, it could also lead to premature tissue and organ aging
(Campisi & d’Adda di Fagagna, 2007), failure of long-term
expansion of stem cells in vitro (Su et al., 2009) and low efﬁ-
ciency of reprogramming (Esteban et al., 2010). Alleviation of
stem cell senescence could be accomplished by the inhibition of
senescence activators in aging cells, such as p53 (Karlseder
et al., 2002) and p16 (Janzen et al., 2006). Considering future
applications, factor supplementation in cell culture is preferred
than direct genetic manipulation. Small molecules have been
focused on, because of their use in cancer therapy, generation
of induced pluripotent cells (iPSCs) and so on. bpV(pic) is a small
chemical compound that speciﬁcally suppresses PTEN activity
(Rosivatz et al., 2006). A recent work showed that it could inhi-
bit PTEN to activate dormant primordial ovarian follicles both in
mice and in human (Li et al., 2010). As it is reported that PTEN
deletion decreased growth factor dependency of neural
stem⁄progenitor cells in vitro (Groszer et al., 2006), it is also
worth investigating whether bpV(pic) could decrease the need
for growth factors by hSKPs. Interestingly, a recent work pro-
moted the efﬁciency of iPSC derivation by adding Vitamin C
which acted at least in part by inhibiting the activation of p53
and cellular senescence and facilitated reprogramming (Esteban
et al., 2010). It is intriguing to investigate in the future whether
vitamin C or other factors could also alleviate hSKP senescence
and thus optimize culture conditions for hSKPs.
Moreover, we did some preliminary investigation on the signal
pathways that regulate hSKP senescence. Signal pathways that
govern cellular senescence have been concentrated on, yielding
different and seemingly inconsistent results in different systems.
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670Noteworthily, recent studies using gene knockout mice revealed
that the loss of some negative regulators of cell cycle, such as
p53, actually induced overall aging because of accelerated cell
divisionandprematurecelldepletion(Tyneret al.,2002).Speciﬁ-
cally, TAp63 loss led to premature mSKP senescence and skin
aging (Su et al., 2009). Cellular senescence, as a protecting
mechanism from and the ﬁnal consequence triggered by various
insults, is governed by a complex regulatory signal network
whichinvolvesthebalancebetweenmultiplepathwaysandfeed-
back mechanisms. We speculate that cells in different status (not
senescent, senescing or senescent) have distinct signal patterns
and thus respond differently to the modiﬁcation of senescence
regulators. In our system, enhanced activity of Akt in senescing
hSKPscouldreduceaccumulationofp53,p21,andp16andmiti-
gate hSKP senescence. The effects of Akt on these factors have
been well studied. Besides, we found that downstream of Akt,
FoxO3, and GSK-3b were inhibited by PDGF-AA and bpV(pic),
which might be a direct result of Akt activation. This suggested a
potential role of FoxO3 and GSK-3b in senescence inhibition of
hSKPs. We also showed that the effect of PDGF-AA and bpV(pic)
wasnotmainlymediatedbyMAPKpathways.
To summarize, we studied the regulation of hSKPs from an
angle of cellular senescence. Our study provided a link among
stem cell self-renewal, stem cell senescence and the PI3K-Akt
pathway, delivered novel information about hSKP maintenance,
and pointed out new directions for future effort concerning the
practice of these potential dermal stem cells. Nonetheless, much
work still remains to be done to elucidate the detailed mecha-
nisms controlling hSKP self-renewal and senescence in the near
future.
Experimental procedures
Establishment of hSKP suspension culture in vitro
Human foreskin samples were derived from voluntary circumci-
sions with informed consents, and the protocol was approved
by the Ethical Committee of the Institute of Zoology, Chinese
Academy of Sciences. Although we obtained some samples
from donors older than 50 years of age, most of hSKPs in this
study were from donors between 20 and 40 years of age. Fore-
skin samples were kept in ice-cold sterile saline immediately
after surgeries and processed within 5 h. Our method of isolat-
ing dermal cells was modiﬁed from a previous report (Toma
et al., 2005). Brieﬂy, human foreskin biopsies were washed with
sterile saline and subcutaneous tissues were cut off followed by
additional wash. Samples were cut into pieces of 5 · 5 mm and
incubated with 5 mg mL
)1 Dispase (Gibco, NY, USA, http://
www.invitrogen.com) in phosphate-buffered saline (PBS) over-
night at 4  C before the epidermis was ripped off. Dermal pieces
were incubated in 5 mg mL
)1 Collagenase Type IV (Gibco) at
37  C for 4–8 h until no solid tissue was visible. Single cell
suspension was obtained by pipetting and ﬁltering through a
40-lm cell strainer. Cell suspension was centrifuged, washed,
plated in growth medium at a density of 10
6 cells mL
)1 in 6-cm
petri dishes (BD Falcon, CA, USA, http://www.bd.com), and cul-
tured at 37  C with 5% CO2. Basal growth medium was
DMEM⁄F12 (Gibco) supplemented with 20 ng mL
)1 epidermal
growth factor, 40 ng mL
)1 basic ﬁbroblast growth factor (both
from Peprotech, NJ, USA, http://www.peprotech.com), and
2% B27 (Gibco). PDGF-AA (Peprotech), bpV(pic) (Alexis,
Switzerland, http://www.enzolifesciences.com/alexis), LY294002
(Sigma, USA, http://www.sigmaaldrich.com), or Akt inhibitor VIII
(Sigma) was added in some experiments. Penicillin⁄streptomycin
was used in all culture experiments. After 3 days of culture, cells
were transferred toCorning 60-mm ultra-low-attachmentculture
dishes (Corning, USA, http://www.corning.com/lifesciences) to
avoid attachment.
Cell aggregates were seen within 3 days after isolation, and
tight spheres were formed on Day 6. For subculture, medium
was changed every 3 days and cells were passaged every 6 days.
To passage hSKPs, 0.05% trypsin-EDTA (Gibco) was used to dis-
aggregate the spheres. Other cell types were gradually elimi-
nated because of their need for attachment to a surface.
Neonatal murine skin was used to isolate murine SKPs as
described by Toma et al. (2005). Culture methods for murine
SKPs were the same as those for hSKPs.
Differentiation of hSKPs
After 12 days of culture in growth medium, hSKP spheres were
trypsinized and pipetted into single cells. Cells were seeded into
11-mm coverslips precoated with poly-D-lysine⁄Laminin (Sigma)
in 24-well plates. For neuronal differentiation, the medium was
Neurobasal medium (Gibco) with 50 ng mL
)1 nerve growth fac-
tor, 50 ng mL
)1 brain-derived neurotrophic factor, 10 ng mL
)1
NT-3 (all from Peprotech), and 1–5% fetal bovine serum (FBS)
(Hyclone, Australia, http://www.hyclone.com). For Schwann cell
condition, the medium was Neurobasal medium with 1% N2
supplement (Gibco), 4 lM forskolin (Sigma), 10 ng mL
)1 hereg-
ulin (Peprotech), and 1% FBS. For adipocyte differentiation,
DMEM⁄F12 containing 10% FBS, 1 mM dexamethasone
(Sigma), 1 mM isobutylmethylxanthine (Sigma), and 20 lgm L
)1
insulin (Sigma) was used. For spontaneous differentiation, the
medium was DMEM⁄F12 with 1–5% FBS. Differentiation took
2–4 weeks depending on morphology of the cells. Medium was
half-changed every 3 days.
For quantitative differentiation assays, three different condi-
tions described in Table S1 (Supporting information) were used
to assess the derivation of different types of cells. Each condition
was duplicated. At the end of a 21-day differentiation, cells
were ﬁxed and stained for certain markers. Radom ﬁelds were
selected and photographed and percentage of cells positive for
a certain marker was estimated by dividing the number of cells
positive for this marker by the total cell number.
MTS assay and statistics
Day 12 hSKPs were trypsinized and pipetted into single cells.
Cells were seeded into a ultra-low-attachment 24-well plate
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671(Costar, USA, http://www.corning.com/lifesciences) at a density
of 10
5 cells per well in hSKP growth medium plus different fac-
tors. MTS assay was performed using CellTiter 96
  AQueous
One Solution Cell Proliferation Assay (Promega, USA, http://
www.promega.com) according to the manufacturer’s instruc-
tions. MTS assay was applied at 48 h or 0, 24, 48, and 72 h after
cell seeding. Each treatment had triplicates and at least three
independent experiments were performed for statistics. All data
were represented as mean ± SEM. Data were analyzed using
Student’s t-test for comparison between two groups or one-
way ANOVA test for more than two groups. A P-value of 0.05 was
considered signiﬁcant.
Semi-solid culture in methylcellulose-containing
media
Methylcellulose was purchased from Sigma, and 2% methylcel-
lulose in DMEM⁄F12 was made as stock solution. A ﬁnal con-
centration of 0.8% methylcellulose in DMEM⁄F12 was used for
cell culture.
Sphere-forming assay and cell counting
To investigate the time-dependent cell growth, cells in each
group were seeded at a density of 5 · 10
5 cells mL
)1 upon iso-
lation. On Day 6, 12, 18, 24, and 30, sphere numbers were
counted and cells were trypsinized into single cells. Cell numbers
were counted, and sphere-forming rate at each time point was
calculated as the sphere number of 6 days later divided by cell
number of the current time point.
For sphere-forming assay, Day 12 spheres were trypsinized
into single cells and seeded at a density of 10
4 cells per well
of an ultralow-attachment 24-well plate in different media
and cultured for 6 days to investigate the sphere-forming
ability of hSKPs in different culture conditions. Each treat-
ment had triplicates and at least three hSKP samples were
used for analysis. Statistics were carried out as described
above.
Human foreskin-derived SKPs from two independent donors
were used for sphere-forming assay in semisolid culture. Media
containing 0.8% methylcellulose was used instead of liquid
media, and other conditions were the same as in liquid media as
described above.
TUNEL assay
Human foreskin-derived SKP spheres were cytospinned. Cells
were ﬁxed and TUNEL Assay was carried out using an In Situ Cell
Death Detection kit, POD (Roche, USA, http://www.roche-
applied-science.com) according to the manufacturer’s instruc-
tions. For each sphere, total cell number and labeled cell number
were counted. Percentage of labeled cells within each sphere
was calculated and used for statistics that was performed as
described above.
Immunostaining
For sphere staining, hSKP spheres were cytospinned and ﬁxed
with 4% paraformaldehyde (Sigma) in PBS, washed for three
times with PBS, and then permeablized and blocked in PBS with
5% BSA (Sigma) and 0.2% triton-X 100 (Sigma) at 37  C for
1 h. Primary antibodies were applied in PBS with 1% BSA and
0.2% triton-X 100 at 4  C overnight. After washing the slides
with PBS for 3 · 5 min, appropriate secondary antibodies
(Zhongshan Goldenbridge Biotechnology, China, http://
www.zsbio.com) were applied also in PBS with 1% BSA and
0.2% triton-X 100 at 37  C for 1 h. Slides were washed
3 · 5 min before propidium iodide (PI) or Hoechst 33342 (both
form Sigma) was used for nuclear staining. Differentiated cells
on coverslips were ﬁxed and stained as for hSKP spheres. Primary
antibodies used were listed in Table S2 (Supporting informa-
tion).
Ki67-positive cell rate was calculated and data was processed
as described for TUNEL assay.
Oil-red O staining
Differentiated cells on coverslips were ﬁxed with 4% parafor-
maldehyde in PBS for 2 min, washed with PBS for three times
and with 60% isopropanol for two times. Then, cells were incu-
bated in 0.3% Oil-Red O (Sigma) in 60% isopropanol at room
temperature for 1 h, followed by being washed for three times
with 60% isopropanol and three times in distilled water. Hema-
toxylin (Zhongshan Goldenbridge Biotechnology) was used for
counterstaining in some experiments.
SA-b-gal staining and result processing
Human foreskin-derived SKP spheres of different passages or
treatments were cytospinned. SA-b-gal staining was carried out
using a SA-b-gal staining kit (Beyotime Biotechnology, China,
http://www.beyotime.com). According to the extent of staining,
spheres were divided into three groups: spheres with nearly no
staining, spheres with < 50% cells stained blue, and spheres
with ‡ 50% cells stained blue. Numbers of spheres in three
groups were counted and compared. SA-b-gal staining was also
applied for trypsinized hSKPs.
RNA extraction, reverse transcription, and PCR
Generally, total RNAs were prepared from samples using Trizol
reagent (Invitrogen, NY, USA, http://www.invitrogen.com). For
small samples, RNeasy Micro Kit (Qiagen, USA, http://www.
qiagen.com) was used. cDNAs were synthesized using
M-MuLV reverse transcriptase (NEB, China, http://www.
neb-china.com).
The procedure of the PCR was as follows: 94  C for 5 min, 35
cycles of 94  C for 30 s, gene-speciﬁc annealing temperature
for 30 s, and 72  C for 30 s, and 72  C for 5 min.
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672Quantitative real-time PCR was carried out using RealMaster-
Mix (SYBR Green) (Tiangen, China, http://www.tiangen.com),
and the assay was performed in an ABI Prism
  7000 Sequence
Detection System (Appliedbiosystem, USA, http://www.
Appliedbiosystem.com). The PCR procedure is as follows: 94  C
for 2 min followed by 40 cycles of 94  C for 15 s and 60  C for
1 min.
The primers used were listed in Table S3 (Supporting informa-
tion).
Protein extraction and Western blot
Human foreskin-derived SKPs of different passages or treat-
ments were centrifuged and collected. Total protein was
extracted using radioimmunoprecipitation (RIPA) lysis buffer
completed with phenylmethanesulfonyl ﬂuoride (both from
Beyotime Biotechnology). Protein concentration was deter-
mined using a BCA Protein Assay kit (Beyotime Biotechnology).
About 20-lg protein was loaded for each sample in Western
blot. Samples were loaded on 12% sodium dodecyl sulfate poly-
acrylamide gel and transferred onto polyvinyl diﬂuoride mem-
branes. After blocked with 5% nonfat milk in Tris-buffered
saline Tween-20 (TBST pH 7.4) for 1 h at room temperature,
membranes were incubated with primary antibodies in blocking
solution at 4  C overnight. After incubating the membranes
with appropriate secondary antibodies conjugated to horserad-
ish peroxidase (Zhongshan Goldenbridge Biotechnology), detec-
tion was performed with ECL Plus kit Pierce ECL Substrate
(Pierce, USA, http://www.piercenet.com). Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) was used as a loading con-
trol. Antibodies were listed in Table S4 (Supporting informa-
tion). Western blot results were subjected to gray-scale analysis
using Quantity One  software (Bio-Rad Laboratories, http://
www.bio-rad.com), and at least three independent experiments
were used for statistical analysis.
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